Archive:January 2023

1
K&L Gates’ Verticals Predictions for 2023: Top Trends, Opportunities and Pitfalls
2
Breakthrough FDA Decision: Agency Completes Its First Pre-Market Consultation for Human Food Made From Cultured Animal Cells

K&L Gates’ Verticals Predictions for 2023: Top Trends, Opportunities and Pitfalls

By: Gabriela da CostaJennifer P.M. MarshDr. Annette Mutschler-Siebert, M. Jur. (Oxon)Francesco CarloniMichal KoconNikolaos Peristerakis

It has now been six months since the new vertical distribution laws came into effect in the European Union (EU) and United Kingdom (UK). With many consumer brands starting 2023 looking for ways to shore up their resilience and profitability in a challenging market, our EU and UK Antitrust and Competition Law team has jotted down our thoughts on the trends that have gained the most traction under the new rules, big opportunities up for grabs, and lessons learned on pitfalls to avoid.

Read More

Breakthrough FDA Decision: Agency Completes Its First Pre-Market Consultation for Human Food Made From Cultured Animal Cells

By: Natalie Rainer, Alexa Sengupta

On 16 November 2022, the U.S. Food and Drug Administration (FDA) announced that it had completed its first pre-market consultation for “human food made from cultured cells,” also known as “cell-based” foods.[1] “Human food made from cultured animal cells” refers to growing animal cells  in a controlled environment to produce food without sacrificing animals.[2] 

Read More

Copyright © 2024, K&L Gates LLP. All Rights Reserved.